The major objective of the International Conference on Innovations for the Elimination and Control of Visceral Leishmaniasis (IEC-VL) is to bring together leading scientists from academia and industry around the world to deliberate upon new tools, new approaches, and routes to implementation.
Session
VL & PKDL– Current status from control to elimination
Date: Wednesday, 28 November 2018
Time: 11:00-12:20
Chair: Simon Croft, Professor of Parasitology, London School of Hygiene and Tropical Medicine, UK
Co-chair: Shyam Sundar, Medical field, Banaras Hindu University, Varanasi, UP, India
| Elimination of kala-azar in the Indian subcontinent: Lessons from elimination of other neglected diseases Suman Rijal, Head of Regional Office, DNDi in India |
| A path achieved towards kala-azar near-elimination in Bangladesh Rajib Chowdhury, National Institute of Preventive and Social Medicine, Bangladesh |
| Overview of VL in India, past and present Pradeep Das, Director, The Rajendra Memorial Research Institute of Medical Sciences, India |
| PKDL a threat in kala-azar elimination strategy in Indian Subcontinent Ed Zijlstra, Senior Consultant, DNDi |
Epidemiology
Date: Wednesday, 28 November 2018
Time: 15:40-16:40
Chair: Nupur Roy, Additional Director, National Vector Borne Disease Control Program, India
Co-chair: Jorge Alvar, Senior Leishmaniasis Advisor, DNDi, Switzerland
| The pattern of diagnosed cases in time and space during elimination and postelimination of VL in India Graham Medley, Professor, London School of Hygiene and Tropical Medicine, UK |
| Determinants of disease progression and role of asymptomatic Leishmania donovani infection in transmission Om Prakash Singh, Scientist at Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP, India |
| Leishmania donovani variant that causes cutaneous leishmaniasis in Sri Lanka Nadira Karunaweera, Chair and Professor of Parasitology, Colombo University, Sri Lanka |
Transmission
Date: Wednesday, 28 November 2018
Time: 17:20-18:20
Chair: Pradeep Das, Director, The Rajendra Memorial Research Institute of Medical Sciences, India
Co-chair: Mary Cameron, Professor, London School of Hygiene and Tropical Medicine, UK
| Significance of vector challenge in relation to visceral leishmaniasis control: deciphering sand fly-transmitted infections Shaden Kamhawi, The National Institute of Allergy and Infectious Diseases, NIH, USA |
| The role of PKDL patients in the VL transmission in Bangladesh Jorge Alvar, Senior Leishmaniasis Advisor, DNDi, Switzerland |
| When to stop Indoor Residual Spray for Kala- azar elimination R. K. Dasgupta, Ex. Joint Director, National Vector Borne Disease Control Program, India |
Drugs
Date: Thursday, 29 November 2018
Time: 8:30-9:50
Chair: Syamal Roy, Indian Institute of Chemical Biology, India
Co-chair: Dan Zilberstein, Professor of Microbiology at the Faculty of Biology, Technion, Israel Institute of Technology, Israel
| Drug discovery to combat VL in India Neena Goel, Central Drug Research Institute, India |
| Current and future perspectives for the development of innovative treatments for leishmaniasis Fabiana Alves, Head of Visceral Leishmaniasis Clinical Program, DNDi, Switzerland |
| Therapeutic role of cholesterol in experimental visceral leishmaniasis Syamal Roy, Indian Institute of Chemical Biology, India |
| PK/PD as a tool for the development and optimization of new therapies for VL Thomas Dorlo, The Netherlands Cancer Institute, Amsterdam, Netherlands, and DNDi Consultant |
Diagnostics
Date: Thursday, 29 November 2018
Time: 10:10-11:10
Chair: Suman Rijal, Head of Regional Office, DNDi in India
Co-chair: Greg Matlashewski, Interim Chair and Professor, McGill University, Canada
| Post kala-azar dermal leishmaniasis (PKDL): challenges in diagnosis and treatment Poonam Salotra, Deputy Director, National Institute of Pathology, India |
| Diagnosis and management of VL-HIV coinfection within the elimination framework Sakib Burza, Medical Advisor Asia, Médecins Sans Frontières, India |
| Unmet diagnostic needs in leishmaniasis Isra Cruz, Senior Scientific Officer, FIND, Switzerland |
Panel Discussion
Innovations in communications and advocacy needed to sustain the elimination of VL
Date: Thursday, 29 November 2018
Time: 11:10-12:00
Chairs:
- P.K. Sen, Director, National Vector Borne Disease Control Program, India
- N.K. Ganguly, Former DG, Indian Council of Medical Research, India
Speakers:
|
Key outcomes, position paper on research needs and opportunities to sustain VL elimination
Date: Thursday, 29 November 2018
Time: 16:40-18:00
Chairs:
- Piero Olliaro, Centre for Tropical Diseases and Global Health Nuffield Department of Medicine, University of Oxford, UK
- N.K. Ganguly, Former DG, Indian Council of Medical Research, India
- Simon Croft, Professor of Parasitology, London School of Hygiene and Tropical Medicine, UK
Speakers:
|
More information:
